100 % Agree with all you are saying Ted. The company will/should also receive a 45 percent R & D tax incentive rebate on the R & D spend. There is method to putting as much as possible in that category. You don’t build a powerhouse company with only in class drugs that can be sold on a world stage unless you do things properly and to satisfy stringent regulations in other countries. That costs a few dollars. What they have achieved in the last quarter is exceptional.
IHL Price at posting:
6.8¢ Sentiment: Buy Disclosure: Held
